Related Experiment Video
Updated: May 19, 2026
08:56
Working with Auditory HEI-OC1 Cells
Published on: September 3, 2016
[Phaseoloideside E induces human hepatoma HepG2 cells apoptosis].
Shasha Mo1, Guangwen Shu, Hui Xiong
1College of Pharmacy, South Central University for Nationalities, Wuhan 430074, China. moshsha533@gmail.com
Summary
Phaseoloideside E (PE) demonstrates significant anti-tumor effects by inducing apoptosis in human hepatoma HepG2 cells. This compound alters the expression of key apoptosis-related proteins, Bax and Bcl-2, offering potential therapeutic avenues.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Context:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Identifying novel therapeutic agents for HCC is crucial.
- Phaseoloideside E (PE) is a compound with potential biological activities.
Purpose:
- To investigate the in vitro anti-tumor activity of PE against human hepatoma HepG2 cells.
- To elucidate the mechanism of PE-induced cell death.
Summary:
- PE significantly reduced the viability of HepG2 cells in a dose-dependent manner.
- Morphological and biochemical analyses confirmed PE-induced apoptosis, evidenced by DNA laddering.
- Western blot analysis revealed that PE up-regulated Bax expression and down-regulated Bcl-2 expression.
Impact:
- PE exhibits potent apoptosis-inducing effects on HepG2 cells.
- The modulation of Bax and Bcl-2 expression by PE is implicated in its anti-cancer mechanism.
- PE represents a potential candidate for further development as an anti-hepatoma therapeutic.
